Sandbox: Kaposi 2: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
* The optimal therapy for Kaposi's sarcoma depends on multiple factors which include: | * The optimal therapy for Kaposi's sarcoma depends on multiple factors which include:<ref name="pmid22677687">{{cite journal| author=Fatahzadeh M| title=Kaposi sarcoma: review and medical management update. | journal=Oral Surg Oral Med Oral Pathol Oral Radiol | year= 2012 | volume= 113 | issue= 1 | pages= 2-16 | pmid=22677687 | doi=10.1016/j.tripleo.2011.05.011 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22677687 }} </ref> | ||
:* The anatomical location of the tumor | :* The anatomical location of the tumor | ||
:* The specific variant of Kaposi's sarcoma | :* The specific variant of Kaposi's sarcoma | ||
| Line 12: | Line 12: | ||
* Management strategies varies depending on the specific variant of Kaposi's sarcoma such as: | * Management strategies varies depending on the specific variant of Kaposi's sarcoma such as: | ||
:* Classic Kaposi's sarcoma managemenet may range from no treatment to either radiotherapy, local interventions, or surgical excision. | :* Classic Kaposi's sarcoma managemenet may range from no treatment to either radiotherapy, local therapeutic interventions, or surgical excision. | ||
:* Iatrogenic Kaposi's sarcoma management focuses on modifying immunosuppressive therapy in addition to local therapeutic interventions. | |||
:* Endemic Kaposi's sarcoma is primarily manage by systemic chemotherapy | |||
:* There is no curative treatment for epidemic Kaposi's sarcoma; the mainstay management is HAART therapy which aims for the palliation and control of Kaposi's sarcoma progression. | |||
Endemic | |||
Revision as of 18:35, 21 January 2016
- The optimal therapy for Kaposi's sarcoma depends on multiple factors which include:[1]
- The anatomical location of the tumor
- The specific variant of Kaposi's sarcoma
- The rate of distribution and progression of Kaposi's sarcoma lesions
- The patients clinical presentation
- The efficacy and potential side effects of therapy
- The presence or absence of HIV infection
- The degree of immune suppression,
- The presence of other comorbidities
- The degree of host immune competence
- The preference and prognosis of the patients
- Management strategies varies depending on the specific variant of Kaposi's sarcoma such as:
- Classic Kaposi's sarcoma managemenet may range from no treatment to either radiotherapy, local therapeutic interventions, or surgical excision.
- Iatrogenic Kaposi's sarcoma management focuses on modifying immunosuppressive therapy in addition to local therapeutic interventions.
- Endemic Kaposi's sarcoma is primarily manage by systemic chemotherapy
- There is no curative treatment for epidemic Kaposi's sarcoma; the mainstay management is HAART therapy which aims for the palliation and control of Kaposi's sarcoma progression.
- ↑ Fatahzadeh M (2012). "Kaposi sarcoma: review and medical management update". Oral Surg Oral Med Oral Pathol Oral Radiol. 113 (1): 2–16. doi:10.1016/j.tripleo.2011.05.011. PMID 22677687.